Status:
UNKNOWN
Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy
Lead Sponsor:
Alexandria University
Conditions:
Cancer Breast
Chronic Pain Syndrome
Eligibility:
FEMALE
20-70 years
Phase:
PHASE2
PHASE3
Brief Summary
Modified radical mastectomy may be associated with severe post-operative pain, leading to chronic pain syndrome which usually requires optimal perioperative pain management.
Detailed Description
Patients will be randomly into two equal groups (40 patients each) according to the adjuvant added to the local anesthetic (bupivacaine) in the serratus anterior plane block using a computer-generated...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- adult female patients
- American Society Of Anesthesiologists (ASA) class I or II
- scheduled for elective unilateral modified radical mastectomy
- Exclusion Criteria
- patient refusal
- bilateral breast surgery
- coagulation disorders
- body mass index\> 35
- allergy to local anaesthetics or magnesium sulphate
- severe respiratory or cardiac disorders
- pre-existing neurological deficits
- liver or renal insufficiency
Exclusion
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04429893
Start Date
January 1 2022
End Date
September 1 2022
Last Update
August 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rehab Abd Elraof Abd Elaziz
Alexandria, Smouha, Egypt, 000000